List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 304 studies with search of: "Camptothecin"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Aerosolized Liposomal Camptothecin in Patients With Metastatic or Recurrent Cancer of the Endometrium or the Lung
Conditions: Corpus Uteri;   Lung Cancer
Intervention: Drug: 9-NC in aerosol reservoir
2 Completed Pharmacology Study of Aerosolized Liposomal
Conditions: Lung Diseases;   Cancer
Intervention: Drug: L9NC: Liposomal 9-Nitro-20 (S)-Camptothecin
3 Completed Polyglutamate Camptothecin in Treating Patients With Advanced Cancer
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Drug: polyglutamate camptothecin
4 Recruiting Aerosol L9-NC and Temozolomide in Ewing's Sarcoma
Condition: Ewing's Sarcoma
Interventions: Drug: Temozolomide;   Drug: L9-NC
5 Completed Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)
Conditions: Lung Diseases;   Cancer
Intervention: Drug: Liposomal 9-Nitrocamptothecin
6 Completed Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)
Conditions: Corpus Uteri;   Endometrial Cancer
Intervention: Drug: 9-NC in aerosol reservoir
7 Terminated Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophageal Junction
Conditions: Cancer of Stomach;   Gastroesophageal Cancer
Intervention: Drug: Pegamotecan
8 Completed Pharmacology Study of Aerosolized Liposomal 9-Nitro-20 (S)-Camptothecin (L9NC)
Conditions: Corpus Uteri;   Endometrial Cancer
Intervention:
9 Active, not recruiting Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity
Condition: Cancer
Intervention: Drug: aminocamptothecin colloidal dispersion
10 Completed Aminocamptothecin in Treating Patients With Advanced or Recurrent Kidney Cancer
Condition: Kidney Cancer
Intervention: Drug: aminocamptothecin colloidal dispersion
11 Recruiting Safety Study of ON 01910.Na in Combination With Irinotecan or Oxaliplatin
Condition: Advanced Solid Tumors
Interventions: Drug: ON 01910.Na and irinotecan;   Drug: ON 01910.Na and oxaliplatin
12 Recruiting A Pilot Study of the Addition of Bevacizumab to VOIT Regimen for Relapsed/Refractory Pediatric Solid Tumors
Condition: Solid Tumor
Interventions: Drug: Bevacizumab;   Drug: Temozolomide;   Drug: Vincristine sulfate;   Drug: Irinotecan;   Drug: Cefixime or Cefpodoxime
13 Recruiting Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With Hepatoma
Conditions: Hepatoma;   Advanced Solid Tumor
Interventions: Drug: irinotecan and ON 01910.Na;   Drug: oxaliplatin and ON 01910.Na
14 Completed A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin With G-CSF Support in Patients With Advanced Ovarian Cancer Previously Treated With Paclitaxel and Cisplatin
Condition: Ovarian Neoplasms
Intervention: Drug: 9-aminocamptothecin
15 Completed Multicenter Study of 9-Aminocamptothecin (9-AC) in Patients With Refractory Leukemia
Conditions: Acute Myeloid Leukemia (AML);   Acute Lymphoblastic Leukemia (ALL)
Intervention: Drug: 9-Aminocamptothecin (9-AC)
16 Active, not recruiting Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomas
Conditions: Glioblastoma Multiforme;   Glioma
Interventions: Drug: Thalidomide;   Drug: CPT-11;   Procedure: MRI Scan;   Procedure: Quantitative Sensory Tests (QST)
17 Suspended Efficacy and Safety Evaluation of Pegamotecan (PEG-Camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma
Condition: Sarcoma, Soft Tissue
Intervention: Drug: Pegamotecan
18 Completed Nitrocamptothecin in Treating Patients With Metastatic Melanoma
Condition: Melanoma (Skin)
Intervention: Drug: rubitecan
19 Completed Nitrocamptothecin in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer
Conditions: Ovarian Cancer;   Peritoneal Cavity Cancer
Intervention: Drug: rubitecan
20 Completed Nitrocamptothecin in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Condition: Breast Cancer
Intervention: Drug: rubitecan

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services